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Patients with Systemic Lupus Erythematosus (SLE) have an increased risk of cardiovascular 
disease (CVD) and impaired endothelial repair.   Although vitamin D deficiency is associated 
with increased CVD risk in the general population, a causal relationship has not been 
demonstrated.  We aimed to determine whether vitamin D deficiency directly modulates 
endothelial dysfunction and immune responses in a murine model of SLE. 
Methods 
Vitamin D deficiency was induced in lupus-prone MRL/lpr mice by dietary restriction for 6 
weeks.  Endothelium-dependent vasorelaxation was quantified using aortic ring myography 
and endothelial repair mechanisms by quantifying the phenotype and function of bone 
marrow endothelial progenitor cells (EPCs) and an in vivo Matrigel plug model.  Lupus 
disease activity was determined by expression of interferon-sensitive genes (ISGs) in splenic 
tissue, serum autoantibodies and renal histology.  To validate the findings, expression of 
ISGs was also measured in whole blood from vitamin D deficient and replete SLE patients. 
Results 
Vitamin D deficiency resulted in impaired endothelium-dependent vasorelaxation and 
decreases in neoangiogenesis without a change in total number of EPCs.  There were no 
differences in anti-dsDNA titers, proteinuria or glomerulonephritis (activity or chronicity) 
between deficient or replete mice.  Vitamin D deficiency was associated with a trend 
towards increased ISG expression both in mice and in SLE patients. 




Vitamin D deficiency is associated with hampered vascular repair and reduced endothelial 
function, and may modulate type I IFN responses. 
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Patients with systemic lupus erythematosus (SLE) have an increased risk of cardiovascular 
disease (CVD) which is not explained by traditional risk factors (1).  As a surrogate of 
vascular risk, endothelium-dependent vasorelaxation is impaired in lupus patients compared 
to matched controls indicating endothelial dysfunction, a predictor of atherogenesis (2).  As 
a mechanism underlying endothelial dysfunction in SLE, we have proposed that an 
imbalance develops in these patients, where accelerated endothelial cell apoptosis is 
coupled with decreased vascular repair (as manifest by fewer endothelial progenitor cells 
(EPCs) and a reduced ability to differentiate into mature EPCs). We have also proposed that 
type I interferons (IFNs), cytokines increased in SLE patients, are main drivers of the 
decreased vascular repair and atherosclerosis risk in this disease (3). 
Vitamin D deficiency may promote premature CVD in this patient group.  Lupus patients 
have lower serum 25-hydroxyvitamin D (25(OH)D) compared to healthy subjects, which may 
be due in part to sunlight avoidance (4).    Low serum 25(OH)D is associated with endothelial 
dysfunction in the general population (5) and with increased aortic stiffness in SLE patients 
(6). However evidence for a causal relationship between vitamin D deficiency and 
premature CVD in SLE is currently lacking. Furthermore, while vitamin D may be 
immunomodulatory in vitro, the association between vitamin D deficiency and disease 
activity in SLE patients remains controversial. 
We investigated whether induction of vitamin D deficiency modified endothelial function, 
neoangiogenesis and progression of disease in lupus-prone MRL/lpr mice and also analyzed 
the association between vitamin D levels and the type I IFN signature in SLE patients.  





MRL/lpr mice (000485 MRL/MpJ-Faslpr/J) and control MRL/mpj (000486) were purchased 
from The Jackson Laboratory (Bar Harbor, ME, USA) and fed standard chow until 8 weeks of 
age.   Mice were then changed onto a vitamin D-deficient diet (TD.89123) or calcium- and 
phosphate-matched control diet (TD.89124) (both from Harlan Laboratories, WI, USA).  Mice 
were euthanized after 6 weeks on the specialized diet and serum was obtained at this time.  
Plasma samples for parathyroid hormone (PTH) analysis were collected from the tail vein 1 
week prior to euthanasia.  Protocols were approved by the NIAMS Animal Care and Use 
Committee. 
Measurement of vitamin D and PTH levels 
Serum samples obtained at euthanasia were stored at -80°C until use.  25-hydroxyvitamin D 
(25(OH)D) levels were measured using by immunoassay following manufacturer’s 
instructions (Enzo 25(OH) Vitamin D ELISA kit, Enzo Life Sciences (UK) LTD, UK).  Plasma PTH 
was measured using a murine intact (1-84) PTH ELISA kit (ALPCO, New Hampshire, USA) 
following the manufacturer’s instructions. 
Aortic ring myography  
Endothelium-dependent vasorelaxation was measured by aortic ring myography as 
previously described (7).  Following euthanasia, 2mm rings were carefully cut from the 
thoracic aorta to ensure that the endothelium remained intact.  The aortic rings were 
mounted onto a myograph (Danish Myo Technology, Aarhus, Denmark) and bathed in 
warmed, aerated physiological salt solution (PSS).  The rings were equilibrated prior to 
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contraction with PSS containing 100mmol/l KCl (KPSS).  Cumulative concentrations of 
phenylephrine (PE) (10-9mol/l up to 10-5mol/l) were added to produce a dose-response 
curve.  The rings were washed and contracted again with PE (at the EC50).  Cumulative 
concentrations of acetylcholine (ACh) (10-9 mol/l to 10-5mol/l) were added to produce a 
relation dose-response curve. The ACh-mediated relaxation was calculated as the % of PE 
contraction. 
EPC quantification and differentiation into mature endothelial cells (ECs) 
EPCs were obtained from bone marrow and their capacity to differentiate into ECs was 
quantified using fluorescent microscopy as described previously (3).  Briefly, femurs and 
tibias were flushed with a buffer solution (15mM EDTA in Hanks Buffered Salt Solution) and 
bone marrow cells were separated on Histopaque 1083, and plated in triplicate onto 
fibronectin-coated plates (1.3x106/cm2) in MCDM 131 media supplemented with EGM-MV2 
bullet kit (Lonza, Switzerland) and 5% FBS.  Cells were cultured for 1 week with a media 
change every 3 days. On day 7, cells were incubated with 1′-dioctadecyl-3,3,3′,3′-
tetramethylindocarbocyanine perchlorate (diI)–acetylated LDL (dil-ac-LDL, Biomedical 
Technologies, USA) and FITC-conjugated Bandeiraea (Griffonia) Simplicifolia Lectin I (BS-1, 
Vector Laboratories, USA) for 4 hours.  Images from 3 random fields per well were obtained 
using a Leica DMIRB fluorescent inverted microscope (Bannockburn, USA) with an objective 
magnification of ×10 and an Olympus DP30BW camera (Olympus Corporation, Tokyo, 
Japan).  The number of dual positive cells was quantified using Cell C software (The 
Mathworks Inc, USA) and expressed as mean number per high powered field (HPF). 
In vivo Matrigel plug angiogenesis assay 
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Matrigel plug assays were performed as described previously (3).  Briefly, after 5 weeks on 
the diet, 2 plugs comprising 500µl growth factor-reduced Matrigel (Becton Dickinson, USA) 
containing 20nM basic fibroblast growth factor (R&D systems, USA) were injected 
subcutaneously into each animal.  Plugs were removed 1 weeks later and the haemoglobin 
(Hb) concentration was quantified using the 3,3’,5,5’-tetramethylbenzidine method and 
normalized to the weight of the plug. 
Disease activity assessment 
Serum concentration of anti-double-stranded (ds)-DNA and total IgG was measured using 
the Mouse Anti-dsDNA IgG ELISA kit and Mouse IgG ELISA kit, respectively (both from Alpha 
Diagnostic International, Texas, USA), following manufacturer’s instructions.   
The expression of interferon sensitive genes (ISGs) was determined in the spleen using real-
time RT-qPCR.  Splenic tissue was harvested at euthanasia and stored at -80°C in RNAlater 
(Qiagen, Germany).  RNA was extracted from homogenized tissue using the mRNA Mini kit 
(Qiagen).  RNA was reverse transcribed using iScript RT Supermix kit (Bio-Rad, 
California,USA).  Real-time qPCR was carried out using an ABI 7500 machine and Bio-Rad 
SYBR green iQ™ kit (Bio-Rad).  The following primers were used: MCP1 (forward; 
AGGTCCCTGTCATGCTTCTG, reverse; GGATCATCTTGCTGGTGAAT), IRF7 (forward; 
TGCTGTTTGGAGACTGGCTAT, reverse; TCCAAGCTCCCGGCTAAGT), ISG15 (forward; 
CAGAAGCAGACTCCTTAATTC, reverse; AGACCTCATATATGTTGCTGTG), IFNG (forward; 
AGCGGCTGACTGAACTCAGATTGTA, reverse; GTCACAGTTTTCAGCTGTATAGGG), ACTB 
(forward; TGGAATCCTGTGGCATCCTGAAAC, reverse; TAAAACGCAGCTCAGTAACAGTCCG).  
Gene expression was normalized to the reference gene (ACTB) and then to samples 
obtained from the MRL/mpj control strain using the ΔΔCt method. 
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Renal histology and urinalysis 
Immune complex deposition was assessed by immunofluorescence staining of IgG and C3 on 
frozen kidney sections as described previously (7) and were semi-quantitatively scored by a 
renal pathologist (AZR).  Renal activity and chronicity indexes were scored blindly by a renal 
pathologist (AZR) on formalin-fixed sections stained with Trichrome and PAS as previously 
reported.  Urine albumin and creatinine were quantified using the mouse Albuwell ELISA 
and Creatinine Companion Kit (Exocell, Pennsylvania, USA) and albumin:creatinine ratios 
were calculated. 
Patient recruitment 
Patients with SLE were recruited from a single UK center (Central Manchester University 
Hospitals NHS Foundation Trust).  Serum vitamin D was measured using liquid 
chromatography-mass spectrometry (LC-MS).  Vitamin D deficiency was defined as 
25(OH)D<20ng/ml (50nmol/l) and replete levels were defined as 25(OH)D>30ng/ml 
(75nmol/l).  Disease activity was measured using the Systemic Lupus Erythematosus Disease 
Activity Index 2000 (SLEDAI-2K) score (8).  Informed consent was obtained from all study 
participants, in compliance with the Declaration of Helsinki and the study was approved by 
the North West 1 Research Ethics Committee (11/NW/0008). 
Gene expression analysis  
Peripheral blood from 10 vitamin D-deficient and 10 vitamin D-replete SLE patients was 
collected into PAXgene tubes which were kept at room temperature for 24-48 hours, then 
stored at -80°C until analyzed.  RNA was extracted and quantitative RT-PCR was performed 
as described previously (9).  Total RNA was extracted from whole blood using the PAXgene 
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RNA Isolation Kit (PreAnalytix, Switzerland).  Quantitative RT-PCR was carried out using 
TaqMan Universal PCR Mastermix (Applied Biosystems, UK).  TaqMan probes were used for 
the ISGs; IFI27 (Hs01086370_m1), IFI44L (Hs00199115_m1), IFIT1 (Hs00356631_g1), ISG15 
(Hs00192713_m1), RSAD2 (Hs01057264_m1) and SIGLEC1 (Hs00988063_m1), and for the 
reference genes; HPRT1 (Hs03929096_g1) and 18s (Hs999999001_s1).  The relative 
abundance of each gene was normalized to the expression of HPRT1 and 18s using the 
Applied Biosystems StepOne software (version 2.1).  The values were also expressed as a 
total ISG score as described previously (9). 
Statistical analysis 
Statistical analyses (Student’s t-test) were carried out using Prism v6.04 (GraphPad, USA).  
  




Dietary absence of cholecalciferol rapidly depletes serum vitamin D in mice 
The growth rate for the mice exposed to vitamin-D deficient diet was comparable to mice 
on the control diet over the course of the study and there were no phenotypic differences in 
the mice in terms of body weight, cardiac weight or alopecia (n=10 in each group, data not 
shown). 
Compared to the control diet, mice on the vitamin D-deficient diet had significantly lower 
serum 25(OH)D after 6 weeks (mean [sd] 26.1 [1.6] vs. 65.0 [2.5] nmol/l, p<0.0001).  Plasma 
PTH levels after 5 weeks were also higher in mice receiving the vitamin D deficient diet 
(179.5 [91.8] vs. 76.8 [11.3] pg/ml, p=0.006).  Serum calcium levels after 6 weeks did not 
differ between the groups (0.33 [0.05] vs. 0.35 [0.04] mg/ml, p=0.376). 
 
Vitamin D deficient lupus-prone MLR/lpr mice have impaired endothelium-dependent 
vasorelaxation 
Impaired endothelium-dependent vasorelaxation develops rapidly in MRL/lpr mice 
compared to the background strain (7).  Following 6 weeks of vitamin D deficient diet, 
MRL/lpr mice had significantly impaired endothelium-dependent vasorelaxation compared 
to the mice on the control diet (figure 1). 
Given that reduced endothelium-mediated vasorelaxation is associated with a reduction in 
the capacity of EPCs to differentiate into mature ECs, and with impaired neoangiogenesis, 
we investigated whether either of these parameters was impaired in vitamin D-deficient 
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mice.  The mean number of mature ECs per HPF, following proangiogenic stimulation of 
EPCs, was similar in the vitamin D-deficient mice compared to the replete mice (105 [37] vs. 
123 [35], p=0.309) (figure 1).  EC differentiation was enhanced when EPCs were exposed in 
vitro to the active form of vitamin D (10nM 1,25(OH)2D3) in the deficient, but not the replete 
mice (mean change of 14.1 [7.4] vs. -5.0 [9.8], p=0.067). 
Neoangiogenesis was measured using an in vivo Matrigel plug assay.  These experiments 
were carried out in a separate group of mice to ensure that components of the Matrigel did 
not affect the myography experiments.  The mice on the vitamin D-deficient diet had 
significantly impaired angiogenesis compared to those on the control diet (mean 
concentration of Hb/gram plug 226 [93] vs. 583 [96] µg/ml per g plug, p=0.0228).   
Overall, these results indicate that vitamin D deficiency impairs endothelium-dependent 
vasorelaxation and neoangiogenic capacity in lupus-prone mice. 
 
Effects of vitamin-D deficiency on renal disease and autoantibodies  
At euthanasia, there were no differences in splenic weight or lymphadenopathy between 
experimental groups.  There was no difference between vitamin D deficient and replete 
mice in the levels of anti-dsDNA (3.63[0.75] vs. 2.99[0.42]106 U/ml, p=0.471) or total IgG 
(98.3[10.6] vs. 98.9[5.0]mg/ml, p=0.955).  Similarly, there was no difference in the anti-
dsDNA:IgG ratio (figure 2). 
No differences were observed between deficient and replete mice in the urinary albumin 
concentration (2.58[2.3] vs. 5.47[5.9]µg/ml, p=0.194) or albumin:creatinine ratio (1.80[2.9] 
vs. 1.36[1.2], p=0.699).  Mice in both groups developed a similar degree of histological 
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glomerulonephritis activity and chronicity (using semi-quantitative lupus nephritis activity 
and chronicity score) and similar degrees of immune complex (IgG/C3) deposition (figure 2). 
 
Vitamin D-deficient lupus-prone mice and SLE patients have upregulation of ISGs  
We have previously shown that type I IFNs drive endothelial dysfunction and atherosclerotic 
plaque burden in murine models (3).  We therefore investigated whether vitamin D 
deficiency modified ISG expression in MRL/lpr mice as a putative mechanism to explain how 
vitamin D modulates angiogenesis and vasomotor function.  Splenic expression of  the ISGs 
MCP1, IRF7, ISG15 and IFNG was increased in the vitamin D deficient group compared to the 
control mice, although only the expression of MCP1 reached statistical significance (p=0.036 
for MCP1) (figure 3). 
We then examined the association between vitamin D levels and ISG expression in a small 
number of patients with clinically stable SLE (defined as not requiring any change in 
therapy).  Whole blood expression of ISGs was measured in 10 deficient and 10 replete 
patients who had a mean (sd) serum 25(OH)D of 30.3 (10.8) and 101.4 (23.8) nmol/l 
respectively.  The mean (sd) SLEDAI-2K score was 1.3 (1.9) in deficient patients and 1.4 (1.7) 
in replete patients (p=0.863).  An ISG score was calculated as the median fold change of the 
6 ISGs compared to the median of 20 healthy controls.  The mean ISG score showed a trend 
toward being higher in the deficient patients compared to the vitamin D-replete patients 
(mean [sd] 9.20 [7.5] vs. 4.54 [4.7], p=0.115) (figure 3).  Similarly to the observation in the 
mice, the expression of all of the ISGs (IFI27, IFI44L, IFIT1, ISG15, RSAD2, SIGLEC1) tended to 
be higher in the vitamin D deficient patients. 




Vitamin D deficiency is proposed to be an important risk factor for CVD development in the 
general population (10).  In SLE, lower levels are associated with vascular stiffness (6) and 
increased traditional CVD risk factors (11).  Epidemiological studies are not, however, able to 
demonstrate a causal relationship between low vitamin D and CVD.  Our results provide the 
first evidence that vitamin D deficiency can accelerate the development of endothelial 
dysfunction and impair angiogenesis in murine lupus. These differences occurred at clinically 
relevant 25(OH)D concentrations and in a controlled environment, excluding common 
confounding factors such as concomitant medication, ethnic differences, UV exposure and 
disease duration  Given the pleotropic effects of vitamin D, the mechanisms underlying our 
observations may be complex, and require further study. 
The vitamin D deficient diet induced a state of hyperparathyroidism in the mice.  Although 
the observed changes in vascular function could be due increased PTH, an interventional 
study by Sugden et. al. (2007) identified that vitamin D improved endothelial function in 
patients with type 2 diabetes without any change in PTH (12). 
Importantly, two small clinical studies suggest that vitamin D therapy can modify endothelial 
function, and thus potentially reduce CVD risk, in SLE patients.  A pilot study of 9 SLE 
patients demonstrated that treatment with cholecalciferol can improve endothelial function 
(13).  In this study, patients with an increase in flow-mediated dilatation (FMD) had 
significantly higher post-treatment 25(OH)D levels, although there was no clear correlation 
between 25(OH)D and change in FMD.  In a larger observational study of 40 patients, a 
significant association between changes in serum 25(OH)D and FMD improvement was 
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observed over 12 weeks, in association with increased numbers of pro-angiogenic myeloid 
cells, implicating that changes in endothelial repair were involved (14).  
We have proposed that a failure of endothelial repair is an important contributor to 
premature CVD in SLE patients.  While studies of circulating EPC numbers in SLE have shown 
conflicting results (reviewed in (15)), it is clear that EPCs are dysfunctional in SLE in terms of 
migratory and angiogenic capacity, and pro-angiogenic factor production).  In the present 
study, while the number of EPCs and their capacity to differentiate into mature ECs was not 
influenced by vitamin D status, differentiation improved with in vitro vitamin D 
supplementation in depleted-mice.  In addition, vitamin D deficient mice demonstrated 
reduced in vivo neoangiogenesis suggesting relevant functional impairments.  
In both the murine model and the SLE patients, vitamin D deficiency was associated with 
increased expression of ISGs, although this was not statistically significant in the patients.  
The number of SLE patients included in this pilot study was small, and a larger cohort is 
needed to further investigate this finding.  However, our findings support those of Mandal 
et. al (2014) who demonstrated an inverse association between serum 25(OH)D and both 
IFNα and SLEDAI score (16).  Our results suggest that low vitamin D may drive type I IFN 
pathways resulting in increased ISG expression in the absence of other markers of active 
disease (anti-dsDNA levels, renal disease).  Supporting the murine findings, the relationship 
between low 25(OH)D and increased ISG expression was observed in patients in clinical 
remission in our study, although this requires further validation.  This suggests that vitamin 
D deficiency may contribute to “prime” the immune system in SLE even when there is no 
evidence of overt disease flare and that IFN may contribute to vascular damage perhaps 
independently of clinical disease activity. 
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Whilst we have demonstrated that vitamin D deficiency promotes endothelial dysfunction 
and IFN activation it cannot be assumed that vitamin D treatment reverses these processes.  
In a small study by Aranow et. al. (2105) (17), vitamin D therapy had no effect on the 
expression of ISGs in SLE patients.  However, the effect of cholecalciferol may have been 
diluted in this study since only 16/33 (48%) patients were vitamin D-replete at the end of 
the study and the assessments were done only after 12 weeks of therapy.  Further work is 
therefore needed to determine the reversibility of changes in endothelial function and 
disease activity due to vitamin D deficiency in SLE.  
In summary we have shown that vitamin D deficiency can promote endothelial dysfunction, 
disruptions in neoangiogenesis, and may activate the type I IFN pathway in SLE.  Vitamin D 
replacement may therefore offer a novel and safe strategy to reduce CVD risk in lupus.  A 
well-conducted randomized trial is required to identify the optimal serum 25(OH)D level in 
this patient group and to determine the effects of vitamin D therapy on future clinical CVD 
events.  
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Figure 1: Reduced endothelial-dependent vasorelaxation and neoangiogenesis in vitamin D-
deficient MRL/lpr mice 
A, Reduced acetylcholine (ACh)-mediated vasorelaxation in vitamin D deficient MRL/lpr mice 
compared to those fed a vitamin D-replete diet.  Values are the mean ± SEM for n=8 deficient and 
n=9 control mice, *p<0.05.  B, Endothelial cell differentiation in vitro is no different in vitamin D 
deficient compared to replete mice (n=10 in each group).  C, Reduced in vivo neoangiogenesis in 
vitamin D deficient MRL/lpr mice.  Neoangiogenesis was quantified as the concentration of murine 
haemoglobin (Hb) in the subcutaneous Matrigel plug, adjusted for the plug weight (bar shows the 
mean of n=6 plugs from 3 deficient mice and n=7 plugs from 4 control diet mice), *p<0.05.  EC50=50% 
response contraction. 
Figure 2: Autoantibody production and renal disease in MRL/lpr mice is not associated to vitamin 
D status in lupus-prone mice 
A, Autoantibody production is not modulated by vitamin D status in MRL/lpr mice.  The graph shows 
the means of the ratio of anti-dsDNA antibodies to total serum IgG for n=10 mice in each group. B, 
Urinary albumin:creatinine ratio was similar in both groups, horizontal bar shows the mean value of 
n=9 deficient n=8 control diet mice.  C, Renal activity and chronicity scores were comparable in both 
groups, the horizontal bar shows the mean score of n=10 mice in each group. D, IgG and C3 
complement deposition scores were similar in vitamin D deficient and replete mice.  The bar shows 
the mean ± SEM deposition score (n=9 deficient and n=10 replete mice). 
Figure 3: Vitamin D deficiency is associated with increased type-1 interferon signalling in MRL/lpr 
mice and SLE patients 
A, Expression of all 4 ISGs was higher in the vitamin D-deficient mice. Expression of MCP1 (relative to 
the MRL/MpJ control strain) was significantly increased in the vitamin D deficient mice (bar show 
mean ± SEM expression of n=10 deficient mice and n=10 control diet mice, *p<0.05).  B, Expression 
of each ISG was higher in vitamin D deficient patients.  The bars show the mean ± SEM expression 
(normalised to 2 reference genes). C, The ISG score tended increased in vitamin D deficient SLE 
patients compared to vitamin D replete patients.  Data points show the calculated ISG score for n=10 
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